Amgen's expenditure on research and development by category 2012-2019

This statistic shows the expenditure on research and development of biotech company Amgen in 2012 to 2019, sorted by category. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. Amgen's R&D expenses amounted to approximately 4.1 billion U.S. dollars in 2019. Of that amount, some 1.06 billion U.S. dollars were spent on later stage clinical programs.

Amgen's expenditure on research and development in 2012 to 2019, by category

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

Worldwide

Survey time period

2012 to 2019

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Amgen"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.